The Biosimilars market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Biosimilars market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Biosimilars market.
Key players in the global Biosimilars market covered in Chapter 2 and Chapter 6:
Mabxience SA
Celltrion Healthcare
Biocad
Amega Biotech
Amgen Inc.
Eli Lilly and Company
Biocon Limited
Novartis AG
Dr. Reddy's Laboratories
Samsung Bioepis Co. Ltd
Pfizer Inc.
Stada Arzneimittel AG
Boehringer Ingelheim GmbH
Mylan NV (Viatris Inc.)
LG Life Sciences (LG Chem)
Probiomed SA de CV
Teva Pharmaceutical Industries Ltd
Apotex Inc.
Frezenius Kabi (Frezenius SE & Co. KGaA)
Gedeon Richter PLC
Intas Pharmaceutical Ltd
Coherus Biosciences Inc.
In Chapter 8 and Chapter 10.3, based on types, the Biosimilars market from 2017 to 2029 is primarily split into:
Monoclonal Antibodies
Recombinant Hormones
Immunomodulators
Anti-Inflammatory Agents
Other Product Classes
In Chapter 9 and Chapter 10.4, based on applications, the Biosimilars market from 2017 to 2029 covers:
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Oncology
Other Applications
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Latin America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Biosimilars market, containing global revenue and CAGR. The forecast and analysis of Biosimilars market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 introduces the industrial chain of Biosimilars. Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.
Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Biosimilars industry, consumer behavior analysis.
Chapter 6 provides a full-scale analysis of major players in Biosimilars industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 7 pays attention to the sales, revenue, price and gross margin of Biosimilars in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 gives a worldwide view of Biosimilars market. It includes sales, revenue, price, market share and the growth rate by type.
Chapter 9 focuses on the application of Biosimilars, by analyzing the consumption and its growth rate of each application.
Chapter 10 prospects the whole Biosimilars market, including the global sales and revenue forecast, regional forecast. It also foresees the Biosimilars market by type and application.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
2022-2029 Global Biosimilars Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)
Table of Content
1 Biosimilars Market Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Biosimilars Segment by Type
1.2.1 Global Biosimilars Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of Monoclonal Antibodies
1.2.3 The Market Profile of Recombinant Hormones
1.2.4 The Market Profile of Immunomodulators
1.2.5 The Market Profile of Anti-Inflammatory Agents
1.2.6 The Market Profile of Other Product Classes
1.3 Global Biosimilars Segment by Application
1.3.1 Biosimilars Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Blood Disorders
1.3.3 The Market Profile of Growth Hormonal Deficiency
1.3.4 The Market Profile of Chronic and Autoimmune Disorders
1.3.5 The Market Profile of Oncology
1.3.6 The Market Profile of Other Applications
1.4 Global Biosimilars Market, Region Wise (2017-2022)
1.4.1 Global Biosimilars Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Biosimilars Market Status and Prospect (2017-2022)
1.4.3 Europe Biosimilars Market Status and Prospect (2017-2022)
1.4.3.1 Germany Biosimilars Market Status and Prospect (2017-2022)
1.4.3.2 UK Biosimilars Market Status and Prospect (2017-2022)
1.4.3.3 France Biosimilars Market Status and Prospect (2017-2022)
1.4.3.4 Italy Biosimilars Market Status and Prospect (2017-2022)
1.4.3.5 Spain Biosimilars Market Status and Prospect (2017-2022)
1.4.3.6 Russia Biosimilars Market Status and Prospect (2017-2022)
1.4.3.7 Poland Biosimilars Market Status and Prospect (2017-2022)
1.4.4 China Biosimilars Market Status and Prospect (2017-2022)
1.4.5 Japan Biosimilars Market Status and Prospect (2017-2022)
1.4.6 India Biosimilars Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Biosimilars Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Biosimilars Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Biosimilars Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Biosimilars Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Biosimilars Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Biosimilars Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Biosimilars Market Status and Prospect (2017-2022)
1.4.8 Latin America Biosimilars Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Biosimilars Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Biosimilars Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Biosimilars Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Biosimilars Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Biosimilars Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Biosimilars Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Biosimilars Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Biosimilars Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Biosimilars Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Biosimilars Market Status and Prospect (2017-2022)
1.5 Global Market Size of Biosimilars (2017-2029)
1.5.1 Global Biosimilars Revenue Status and Outlook (2017-2029)
1.5.2 Global Biosimilars Sales Status and Outlook (2017-2029)
2 Global Biosimilars Market Landscape by Player
2.1 Global Biosimilars Sales and Share by Player (2017-2022)
2.2 Global Biosimilars Revenue and Market Share by Player (2017-2022)
2.3 Global Biosimilars Average Price by Player (2017-2022)
2.4 Global Biosimilars Gross Margin by Player (2017-2022)
2.5 Biosimilars Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Biosimilars Market Competitive Situation and Trends
2.6.1 Biosimilars Market Concentration Rate
2.6.2 Biosimilars Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion
3 Biosimilars Upstream and Downstream Analysis
3.1 Biosimilars Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-19
4 Biosimilars Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Biosimilars Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Biosimilars Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis
5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Biosimilars
5.3.2 Increased Demand in Emerging Markets
5.4 Biosimilars Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Biosimilars Industry Development
5.5 Consumer Behavior Analysis
6 Players Profiles
6.1 Mabxience SA
6.1.1 Mabxience SA Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Biosimilars Product Profiles, Application and Specification
6.1.3 Mabxience SA Biosimilars Market Performance (2017-2022)
6.1.4 Mabxience SA Business Overview
6.2 Celltrion Healthcare
6.2.1 Celltrion Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 Biosimilars Product Profiles, Application and Specification
6.2.3 Celltrion Healthcare Biosimilars Market Performance (2017-2022)
6.2.4 Celltrion Healthcare Business Overview
6.3 Biocad
6.3.1 Biocad Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 Biosimilars Product Profiles, Application and Specification
6.3.3 Biocad Biosimilars Market Performance (2017-2022)
6.3.4 Biocad Business Overview
6.4 Amega Biotech
6.4.1 Amega Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 Biosimilars Product Profiles, Application and Specification
6.4.3 Amega Biotech Biosimilars Market Performance (2017-2022)
6.4.4 Amega Biotech Business Overview
6.5 Amgen Inc.
6.5.1 Amgen Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.5.2 Biosimilars Product Profiles, Application and Specification
6.5.3 Amgen Inc. Biosimilars Market Performance (2017-2022)
6.5.4 Amgen Inc. Business Overview
6.6 Eli Lilly and Company
6.6.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Competitors
6.6.2 Biosimilars Product Profiles, Application and Specification
6.6.3 Eli Lilly and Company Biosimilars Market Performance (2017-2022)
6.6.4 Eli Lilly and Company Business Overview
6.7 Biocon Limited
6.7.1 Biocon Limited Basic Information, Manufacturing Base, Sales Area and Competitors
6.7.2 Biosimilars Product Profiles, Application and Specification
6.7.3 Biocon Limited Biosimilars Market Performance (2017-2022)
6.7.4 Biocon Limited Business Overview
6.8 Novartis AG
6.8.1 Novartis AG Basic Information, Manufacturing Base, Sales Area and Competitors
6.8.2 Biosimilars Product Profiles, Application and Specification
6.8.3 Novartis AG Biosimilars Market Performance (2017-2022)
6.8.4 Novartis AG Business Overview
6.9 Dr. Reddy's Laboratories
6.9.1 Dr. Reddy's Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
6.9.2 Biosimilars Product Profiles, Application and Specification
6.9.3 Dr. Reddy's Laboratories Biosimilars Market Performance (2017-2022)
6.9.4 Dr. Reddy's Laboratories Business Overview
6.10 Samsung Bioepis Co. Ltd
6.10.1 Samsung Bioepis Co. Ltd Basic Information, Manufacturing Base, Sales Area and Competitors
6.10.2 Biosimilars Product Profiles, Application and Specification
6.10.3 Samsung Bioepis Co. Ltd Biosimilars Market Performance (2017-2022)
6.10.4 Samsung Bioepis Co. Ltd Business Overview
6.11 Pfizer Inc.
6.11.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.11.2 Biosimilars Product Profiles, Application and Specification
6.11.3 Pfizer Inc. Biosimilars Market Performance (2017-2022)
6.11.4 Pfizer Inc. Business Overview
6.12 Stada Arzneimittel AG
6.12.1 Stada Arzneimittel AG Basic Information, Manufacturing Base, Sales Area and Competitors
6.12.2 Biosimilars Product Profiles, Application and Specification
6.12.3 Stada Arzneimittel AG Biosimilars Market Performance (2017-2022)
6.12.4 Stada Arzneimittel AG Business Overview
6.13 Boehringer Ingelheim GmbH
6.13.1 Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Competitors
6.13.2 Biosimilars Product Profiles, Application and Specification
6.13.3 Boehringer Ingelheim GmbH Biosimilars Market Performance (2017-2022)
6.13.4 Boehringer Ingelheim GmbH Business Overview
6.14 Mylan NV (Viatris Inc.)
6.14.1 Mylan NV (Viatris Inc.) Basic Information, Manufacturing Base, Sales Area and Competitors
6.14.2 Biosimilars Product Profiles, Application and Specification
6.14.3 Mylan NV (Viatris Inc.) Biosimilars Market Performance (2017-2022)
6.14.4 Mylan NV (Viatris Inc.) Business Overview
6.15 LG Life Sciences (LG Chem)
6.15.1 LG Life Sciences (LG Chem) Basic Information, Manufacturing Base, Sales Area and Competitors
6.15.2 Biosimilars Product Profiles, Application and Specification
6.15.3 LG Life Sciences (LG Chem) Biosimilars Market Performance (2017-2022)
6.15.4 LG Life Sciences (LG Chem) Business Overview
6.16 Probiomed SA de CV
6.16.1 Probiomed SA de CV Basic Information, Manufacturing Base, Sales Area and Competitors
6.16.2 Biosimilars Product Profiles, Application and Specification
6.16.3 Probiomed SA de CV Biosimilars Market Performance (2017-2022)
6.16.4 Probiomed SA de CV Business Overview
6.17 Teva Pharmaceutical Industries Ltd
6.17.1 Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base, Sales Area and Competitors
6.17.2 Biosimilars Product Profiles, Application and Specification
6.17.3 Teva Pharmaceutical Industries Ltd Biosimilars Market Performance (2017-2022)
6.17.4 Teva Pharmaceutical Industries Ltd Business Overview
6.18 Apotex Inc.
6.18.1 Apotex Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.18.2 Biosimilars Product Profiles, Application and Specification
6.18.3 Apotex Inc. Biosimilars Market Performance (2017-2022)
6.18.4 Apotex Inc. Business Overview
6.19 Frezenius Kabi (Frezenius SE & Co. KGaA)
6.19.1 Frezenius Kabi (Frezenius SE & Co. KGaA) Basic Information, Manufacturing Base, Sales Area and Competitors
6.19.2 Biosimilars Product Profiles, Application and Specification
6.19.3 Frezenius Kabi (Frezenius SE & Co. KGaA) Biosimilars Market Performance (2017-2022)
6.19.4 Frezenius Kabi (Frezenius SE & Co. KGaA) Business Overview
6.20 Gedeon Richter PLC
6.20.1 Gedeon Richter PLC Basic Information, Manufacturing Base, Sales Area and Competitors
6.20.2 Biosimilars Product Profiles, Application and Specification
6.20.3 Gedeon Richter PLC Biosimilars Market Performance (2017-2022)
6.20.4 Gedeon Richter PLC Business Overview
6.21 Intas Pharmaceutical Ltd
6.21.1 Intas Pharmaceutical Ltd Basic Information, Manufacturing Base, Sales Area and Competitors
6.21.2 Biosimilars Product Profiles, Application and Specification
6.21.3 Intas Pharmaceutical Ltd Biosimilars Market Performance (2017-2022)
6.21.4 Intas Pharmaceutical Ltd Business Overview
6.22 Coherus Biosciences Inc.
6.22.1 Coherus Biosciences Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.22.2 Biosimilars Product Profiles, Application and Specification
6.22.3 Coherus Biosciences Inc. Biosimilars Market Performance (2017-2022)
6.22.4 Coherus Biosciences Inc. Business Overview
7 Global Biosimilars Sales and Revenue Region Wise (2017-2022)
7.1 Global Biosimilars Sales and Market Share, Region Wise (2017-2022)
7.2 Global Biosimilars Revenue (Revenue) and Market Share, Region Wise (2017-2022)
7.3 Global Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.4.1 United States Biosimilars Market Under COVID-19
7.5 Europe Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.5.1 Europe Biosimilars Market Under COVID-19
7.6 China Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.6.1 China Biosimilars Market Under COVID-19
7.7 Japan Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.7.1 Japan Biosimilars Market Under COVID-19
7.8 India Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.8.1 India Biosimilars Market Under COVID-19
7.9 Southeast Asia Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.9.1 Southeast Asia Biosimilars Market Under COVID-19
7.10 Latin America Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.10.1 Latin America Biosimilars Market Under COVID-19
7.11 Middle East and Africa Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.11.1 Middle East and Africa Biosimilars Market Under COVID-19
8 Global Biosimilars Sales, Revenue (Revenue), Price Trend by Type
8.1 Global Biosimilars Sales and Market Share by Type (2017-2022)
8.2 Global Biosimilars Revenue and Market Share by Type (2017-2022)
8.3 Global Biosimilars Price by Type (2017-2022)
8.4 Global Biosimilars Sales Growth Rate by Type (2017-2022)
8.4.1 Global Biosimilars Sales Growth Rate of Monoclonal Antibodies (2017-2022)
8.4.2 Global Biosimilars Sales Growth Rate of Recombinant Hormones (2017-2022)
8.4.3 Global Biosimilars Sales Growth Rate of Immunomodulators (2017-2022)
8.4.4 Global Biosimilars Sales Growth Rate of Anti-Inflammatory Agents (2017-2022)
8.4.5 Global Biosimilars Sales Growth Rate of Other Product Classes (2017-2022)
9 Global Biosimilars Market Analysis by Application
9.1 Global Biosimilars Consumption and Market Share by Application (2017-2022)
9.2 Global Biosimilars Consumption Growth Rate by Application (2017-2022)
9.2.1 Global Biosimilars Consumption Growth Rate of Blood Disorders (2017-2022)
9.2.2 Global Biosimilars Consumption Growth Rate of Growth Hormonal Deficiency (2017-2022)
9.2.3 Global Biosimilars Consumption Growth Rate of Chronic and Autoimmune Disorders (2017-2022)
9.2.4 Global Biosimilars Consumption Growth Rate of Oncology (2017-2022)
9.2.5 Global Biosimilars Consumption Growth Rate of Other Applications (2017-2022)
10 Global Biosimilars Market Forecast (2022-2029)
10.1 Global Biosimilars Sales, Revenue Forecast (2022-2029)
10.1.1 Global Biosimilars Sales and Growth Rate Forecast (2022-2029)
10.1.2 Global Biosimilars Revenue and Growth Rate Forecast (2022-2029)
10.1.3 Global Biosimilars Price and Trend Forecast (2022-2029)
10.2 Global Biosimilars Sales and Revenue Forecast, Region Wise (2022-2029)
10.2.1 United States Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.2 Europe Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.3 China Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.4 Japan Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.5 India Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.6 Southeast Asia Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.7 Latin America Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.8 Middle East and Africa Biosimilars Sales and Revenue Forecast (2022-2029)
10.3 Global Biosimilars Sales, Revenue and Price Forecast by Type (2022-2029)
10.4 Global Biosimilars Consumption Forecast by Application (2022-2029)
10.5 Biosimilars Market Forecast Under COVID-19
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Data Source
List of Tables and Figures
Figure Biosimilars Product Picture
Table Global Biosimilars Sales and CAGR (%) Comparison by Type
Table Profile of Monoclonal Antibodies
Table Profile of Recombinant Hormones
Table Profile of Immunomodulators
Table Profile of Anti-Inflammatory Agents
Table Profile of Other Product Classes
Table Biosimilars Consumption (Sales) Comparison by Application (2017-2029)
Table Profile of Blood Disorders
Table Profile of Growth Hormonal Deficiency
Table Profile of Chronic and Autoimmune Disorders
Table Profile of Oncology
Table Profile of Other Applications
Figure Global Biosimilars Market Size (Revenue) and CAGR (%) (2017-2022)
Figure United States Biosimilars Revenue and Growth Rate (2017-2022)
Figure Europe Biosimilars Revenue and Growth Rate (2017-2022)
Figure Germany Biosimilars Revenue and Growth Rate (2017-2022)
Figure UK Biosimilars Revenue and Growth Rate (2017-2022)
Figure France Biosimilars Revenue and Growth Rate (2017-2022)
Figure Italy Biosimilars Revenue and Growth Rate (2017-2022)
Figure Spain Biosimilars Revenue and Growth Rate (2017-2022)
Figure Russia Biosimilars Revenue and Growth Rate (2017-2022)
Figure Poland Biosimilars Revenue and Growth Rate (2017-2022)
Figure China Biosimilars Revenue and Growth Rate (2017-2022)
Figure Japan Biosimilars Revenue and Growth Rate (2017-2022)
Figure India Biosimilars Revenue and Growth Rate (2017-2022)
Figure Southeast Asia Biosimilars Revenue and Growth Rate (2017-2022)
Figure Malaysia Biosimilars Revenue and Growth Rate (2017-2022)
Figure Singapore Biosimilars Revenue and Growth Rate (2017-2022)
Figure Philippines Biosimilars Revenue and Growth Rate (2017-2022)
Figure Indonesia Biosimilars Revenue and Growth Rate (2017-2022)
Figure Thailand Biosimilars Revenue and Growth Rate (2017-2022)
Figure Vietnam Biosimilars Revenue and Growth Rate (2017-2022)
Figure Latin America Biosimilars Revenue and Growth Rate (2017-2022)
Figure Brazil Biosimilars Revenue and Growth Rate (2017-2022)
Figure Mexico Biosimilars Revenue and Growth Rate (2017-2022)
Figure Colombia Biosimilars Revenue and Growth Rate (2017-2022)
Figure Middle East and Africa Biosimilars Revenue and Growth Rate (2017-2022)
Figure Saudi Arabia Biosimilars Revenue and Growth Rate (2017-2022)
Figure United Arab Emirates Biosimilars Revenue and Growth Rate (2017-2022)
Figure Turkey Biosimilars Revenue and Growth Rate (2017-2022)
Figure Egypt Biosimilars Revenue and Growth Rate (2017-2022)
Figure South Africa Biosimilars Revenue and Growth Rate (2017-2022)
Figure Nigeria Biosimilars Revenue and Growth Rate (2017-2022)
Figure Global Biosimilars Sales Status and Outlook (2017-2029)
Table Global Biosimilars Sales by Player (2017-2022)
Table Global Biosimilars Sales Share by Player (2017-2022)
Figure Global Biosimilars Sales Share by Player in 2021
Table Biosimilars Revenue by Player (2017-2022)
Table Biosimilars Revenue Market Share by Player (2017-2022)
Table Biosimilars Price by Player (2017-2022)
Table Biosimilars Gross Margin by Player (2017-2022)
Table Biosimilars Manufacturing Base Distribution and Sales Area by Player
Table Biosimilars Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Figure Biosimilars Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Market Concentration Rate of Raw Materials
Table Downstream Buyers
Figure Manufacturing Cost Structure Analysis
Table Key Raw Materials Introduction of Biosimilars
Figure Price Trend of Key Raw Materials
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Biosimilars Industry Development
Table Mabxience SA Profile
Table Biosimilars Product Profiles, Application and Specification
Table Mabxience SA Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Mabxience SA Revenue and Growth Rate
Figure Mabxience SA Revenue Market Share 2017-2022
Table Celltrion Healthcare Profile
Table Biosimilars Product Profiles, Application and Specification
Table Celltrion Healthcare Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Celltrion Healthcare Revenue and Growth Rate
Figure Celltrion Healthcare Revenue Market Share 2017-2022
Table Biocad Profile
Table Biosimilars Product Profiles, Application and Specification
Table Biocad Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Biocad Revenue and Growth Rate
Figure Biocad Revenue Market Share 2017-2022
Table Amega Biotech Profile
Table Biosimilars Product Profiles, Application and Specification
Table Amega Biotech Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Amega Biotech Revenue and Growth Rate
Figure Amega Biotech Revenue Market Share 2017-2022
Table Amgen Inc. Profile
Table Biosimilars Product Profiles, Application and Specification
Table Amgen Inc. Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Amgen Inc. Revenue and Growth Rate
Figure Amgen Inc. Revenue Market Share 2017-2022
Table Eli Lilly and Company Profile
Table Biosimilars Product Profiles, Application and Specification
Table Eli Lilly and Company Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Eli Lilly and Company Revenue and Growth Rate
Figure Eli Lilly and Company Revenue Market Share 2017-2022
Table Biocon Limited Profile
Table Biosimilars Product Profiles, Application and Specification
Table Biocon Limited Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Biocon Limited Revenue and Growth Rate
Figure Biocon Limited Revenue Market Share 2017-2022
Table Novartis AG Profile
Table Biosimilars Product Profiles, Application and Specification
Table Novartis AG Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Novartis AG Revenue and Growth Rate
Figure Novartis AG Revenue Market Share 2017-2022
Table Dr. Reddy's Laboratories Profile
Table Biosimilars Product Profiles, Application and Specification
Table Dr. Reddy's Laboratories Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Dr. Reddy's Laboratories Revenue and Growth Rate
Figure Dr. Reddy's Laboratories Revenue Market Share 2017-2022
Table Samsung Bioepis Co. Ltd Profile
Table Biosimilars Product Profiles, Application and Specification
Table Samsung Bioepis Co. Ltd Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Samsung Bioepis Co. Ltd Revenue and Growth Rate
Figure Samsung Bioepis Co. Ltd Revenue Market Share 2017-2022
Table Pfizer Inc. Profile
Table Biosimilars Product Profiles, Application and Specification
Table Pfizer Inc. Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Revenue and Growth Rate
Figure Pfizer Inc. Revenue Market Share 2017-2022
Table Stada Arzneimittel AG Profile
Table Biosimilars Product Profiles, Application and Specification
Table Stada Arzneimittel AG Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Stada Arzneimittel AG Revenue and Growth Rate
Figure Stada Arzneimittel AG Revenue Market Share 2017-2022
Table Boehringer Ingelheim GmbH Profile
Table Biosimilars Product Profiles, Application and Specification
Table Boehringer Ingelheim GmbH Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim GmbH Revenue and Growth Rate
Figure Boehringer Ingelheim GmbH Revenue Market Share 2017-2022
Table Mylan NV (Viatris Inc.) Profile
Table Biosimilars Product Profiles, Application and Specification
Table Mylan NV (Viatris Inc.) Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Mylan NV (Viatris Inc.) Revenue and Growth Rate
Figure Mylan NV (Viatris Inc.) Revenue Market Share 2017-2022
Table LG Life Sciences (LG Chem) Profile
Table Biosimilars Product Profiles, Application and Specification
Table LG Life Sciences (LG Chem) Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure LG Life Sciences (LG Chem) Revenue and Growth Rate
Figure LG Life Sciences (LG Chem) Revenue Market Share 2017-2022
Table Probiomed SA de CV Profile
Table Biosimilars Product Profiles, Application and Specification
Table Probiomed SA de CV Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Probiomed SA de CV Revenue and Growth Rate
Figure Probiomed SA de CV Revenue Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd Profile
Table Biosimilars Product Profiles, Application and Specification
Table Teva Pharmaceutical Industries Ltd Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd Revenue and Growth Rate
Figure Teva Pharmaceutical Industries Ltd Revenue Market Share 2017-2022
Table Apotex Inc. Profile
Table Biosimilars Product Profiles, Application and Specification
Table Apotex Inc. Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Apotex Inc. Revenue and Growth Rate
Figure Apotex Inc. Revenue Market Share 2017-2022
Table Frezenius Kabi (Frezenius SE & Co. KGaA) Profile
Table Biosimilars Product Profiles, Application and Specification
Table Frezenius Kabi (Frezenius SE & Co. KGaA) Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Frezenius Kabi (Frezenius SE & Co. KGaA) Revenue and Growth Rate
Figure Frezenius Kabi (Frezenius SE & Co. KGaA) Revenue Market Share 2017-2022
Table Gedeon Richter PLC Profile
Table Biosimilars Product Profiles, Application and Specification
Table Gedeon Richter PLC Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Gedeon Richter PLC Revenue and Growth Rate
Figure Gedeon Richter PLC Revenue Market Share 2017-2022
Table Intas Pharmaceutical Ltd Profile
Table Biosimilars Product Profiles, Application and Specification
Table Intas Pharmaceutical Ltd Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Intas Pharmaceutical Ltd Revenue and Growth Rate
Figure Intas Pharmaceutical Ltd Revenue Market Share 2017-2022
Table Coherus Biosciences Inc. Profile
Table Biosimilars Product Profiles, Application and Specification
Table Coherus Biosciences Inc. Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Coherus Biosciences Inc. Revenue and Growth Rate
Figure Coherus Biosciences Inc. Revenue Market Share 2017-2022
Table Global Biosimilars Sales, Region Wise (2017-2022)
Table Global Biosimilars Sales Market Share, Region Wise (2017-2022)
Figure Global Biosimilars Sales Market Share, Region Wise (2017-2022)
Figure Global Biosimilars Sales Market Share, Region Wise in 2021
Table Global Biosimilars Revenue, Region Wise (2017-2022)
Table Global Biosimilars Revenue Market Share, Region Wise (2017-2022)
Figure Global Biosimilars Revenue Market Share, Region Wise (2017-2022)
Figure Global Biosimilars Revenue Market Share, Region Wise in 2021
Table Global Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table United States Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table Europe Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table China Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table Japan Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table India Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table Southeast Asia Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table Latin America Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table Middle East and Africa Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table Global Biosimilars Sales by Type (2017-2022)
Table Global Biosimilars Sales Market Share by Type (2017-2022)
Figure Global Biosimilars Sales Market Share by Type in 2022
Table Global Biosimilars Revenue by Type (2017-2022)
Table Global Biosimilars Revenue Market Share by Type (2017-2022)
Figure Global Biosimilars Revenue Market Share by Type in 2022
Table Biosimilars Price by Type (2017-2022)
Figure Global Biosimilars Sales Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Biosimilars Sales Growth Rate of Recombinant Hormones (2017-2022)
Figure Global Biosimilars Sales Growth Rate of Immunomodulators (2017-2022)
Figure Global Biosimilars Sales Growth Rate of Anti-Inflammatory Agents (2017-2022)
Figure Global Biosimilars Sales Growth Rate of Other Product Classes (2017-2022)
Table Global Biosimilars Consumption by Application (2017-2022)
Table Global Biosimilars Consumption Market Share by Application (2017-2022)
Table Global Biosimilars Consumption of Blood Disorders (2017-2022)
Table Global Biosimilars Consumption of Growth Hormonal Deficiency (2017-2022)
Table Global Biosimilars Consumption of Chronic and Autoimmune Disorders (2017-2022)
Table Global Biosimilars Consumption of Oncology (2017-2022)
Table Global Biosimilars Consumption of Other Applications (2017-2022)
Figure Global Biosimilars Sales and Growth Rate Forecast (2022-2029)
Figure Global Biosimilars Revenue and Growth Rate Forecast (2022-2029)
Figure Global Biosimilars Price and Trend Forecast (2022-2029)
Figure USA Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure USA Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Europe Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Europe Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure China Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure China Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Japan Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Japan Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure India Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure India Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Southeast Asia Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Southeast Asia Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Latin America Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Latin America Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Middle East and Africa Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Middle East and Africa Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Table Global Biosimilars Market Sales Forecast, by Type
Table Global Biosimilars Sales Volume Market Share Forecast, by Type
Table Global Biosimilars Market Revenue Forecast, by Type
Table Global Biosimilars Revenue Market Share Forecast, by Type
Table Global Biosimilars Price Forecast, by Type
Table Global Biosimilars Market Consumption Forecast, by Application
Table Global Biosimilars Consumption Volume Market Share Forecast, by Application
Table Global Biosimilars Market Revenue Forecast, by Application
Table Global Biosimilars Revenue Market Share Forecast, by Application
Table Global Biosimilars Price Forecast, by Application
Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 147
According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
Global Biosimilar Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 147
According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
Global Biosimilars Market Research Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 2680 Onwards Pages: 167
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 3280 Onwards Pages: 133
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 07-Dec-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Biosimilars market:
According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years.
A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 3280 Onwards Pages: 134
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 2680 Onwards Pages: 160
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 16-Nov-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Biosimilar Monoclonal Antibodies market:
According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
